In vivo verification of proton beam path by using post‐treatment PET/CT imaging
Authors:
- Wen C. HsiWHWen C. Hsi
- Daniel J. IndelicatoDIDaniel J. Indelicato
- Carlos VargasCVCarlos Vargas
- Srividya DuvvuriSDSrividya Duvvuri
- Zuofeng LiZLZuofeng Li
- Jatinder PaltaJPJatinder Palta
- 12 August 2009
- journal article
- Published by Wiley in Medical Physics
- Vol. 36 (9Part1) , 4136-4146
Abstract
Purpose: The purpose of this study is to establish the in vivo verification of proton beam path by using proton‐activated positron emission distributions.Methods: A total of 50 PET/CT imaging studies were performed on ten prostate cancer patients immediately after daily proton therapy treatment through a single lateral portal. The PET/CT and planning CT were registered by matching the pelvic bones, and the beam path of delivered protons was defined in vivo by the positron emission distribution seen only within the pelvic bones, referred to as the PET‐defined beam path. Because of the patient position correction at each fraction, the marker‐defined beam path, determined by the centroid of implanted markers seen in the post‐treatment (post‐Tx) CT, is used for the planned beam path. The angular variation and discordance between the PET‐ and marker‐defined paths were derived to investigate the intrafraction prostate motion. For studies with large discordance, the relative location between the centroid and pelvic bones seen in the post‐Tx CT was examined. The PET/CT studies are categorized for distinguishing the prostate motion that occurred before or after beam delivery. The post‐PET CT was acquired after PET imaging to investigate prostate motion due to physiological changes during the extended PET acquisition.Results: The less than 2° of angular variation indicates that the patient roll was minimal within the immobilization device. Thirty of the 50 studies with small discordance, referred as good cases, show a consistent alignment between the field edges and the positron emission distributions from the entrance to the distal edge. For those good cases, average displacements are 0.6 and 1.3 mm along the anterior‐posterior and superior‐inferior directions, respectively, with 1.6 mm standard deviations in both directions. For the remaining 20 studies demonstrating a large discordance (more than 6 mm in either or ), 13 studies, referred as motion‐after‐Tx cases, also show large misalignment between the field edge and the positron emission distribution in lipomatous tissues around the prostate. These motion‐after‐Tx cases correspond to patients with large changes in volume of rectal gas between the post‐Tx and the post‐PET CTs. The standard deviations for and are 5.0 and 3.0 mm, respectively, for these motion‐after‐Tx cases. The final seven studies, referred to as position‐error cases, which had a large discordance but no misalignment, were found to have deviations of 4.6 and 3.6 mm in and , respectively. The position‐error cases correspond to a large discrepancy on the relative location between the centroid and pelvic bones seen in post‐Tx CT and recorded x‐ray radiographs.Conclusions: Systematic analyses of proton‐activated positron emission distributions provide patient‐specific information on prostate motion () and patient position variability () during daily proton beam delivery. The less than 2 mm of displacement variations in the good cases indicates that population‐based values of and used in margin algorithms for treatment planning at the authors’ institution are valid for the majority of cases. However, a small fraction of PET/CT studies (approximately 14%) with displacement variations may require different margins. Such data are useful in establishing patient‐specific planning target volume margins.Keywords
This publication has 11 references indexed in Scilit:
- Dosimetric uncertainty in prostate cancer proton radiotherapyMedical Physics, 2008
- In Vivo Verification of Dose Delivery to Prostate Cancer by Utilizing PET/CT Images Taken after Proton TherapyInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2008
- Image Guidance Based on Prostate Position for Prostate Cancer Proton TherapyInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2008
- Patient Study of In Vivo Verification of Beam Delivery and Range, Using Positron Emission Tomography and Computed Tomography Imaging After Proton TherapyInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2007
- PET/CT imaging for treatment verification after proton therapy: A study with plastic phantoms and metallic implantsMedical Physics, 2007
- Anatomic feature-based registration for patient set-up in head and neck cancer radiotherapyPhysics in Medicine & Biology, 2005
- Retrospective analysis of prostate cancer patients with implanted gold markers using off-line and adaptive therapy protocolsInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2005
- The probability of correct target dosage: dose-population histograms for deriving treatment margins in radiotherapyInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2000
- On‐line monitoring of radiotherapy beams: Experimental results with proton beamsMedical Physics, 1999
- Analysis of Microcomposition of Biological Tissue by Means of Induced RadioactivityScience, 1949